摘要
目的通过中医传承辅助平台软件分析傅汝林教授治疗淋巴瘤的组方及用药规律。方法通过对傅汝林教授2012年9月至2015年8月期间治疗淋巴瘤的中医治疗处方进行收集、整理以及筛选,将符合标准的数据录入中医传承辅助平台软件(V2.0),运用软件进行数据统计分析,探讨傅汝林教授治疗淋巴瘤的临床特点。结果对筛选出的符合标准的55例处方以及其中涉及到的103味中药进行分析,初步得出傅汝林教授在治疗淋巴瘤方面善用北沙参、南沙参、白芍等益气养阴之品扶助正气,适当辅以鳖甲、莪术等养阴散结之品配合猫爪草、白花蛇舌草、生甘草、夏枯草等清热解毒之品以消癥瘕。结论傅汝林教授治疗淋巴瘤多采用益气养阴、散结解毒之品,再根据不同体质状态临证选药,多辅以理气活血、化痰除湿之品,诸药合用,祛邪扶正,标本兼治,从多途径增强抗癌之效,临床疗效显著,为临床更好地运用中医药治疗淋巴瘤提供了新的治疗思路。
Objective To analyze the prescription and medication rules of Professor FU Rulin in treating lymphoma by using the software of traditional Chinese medicine inheritance support system (TCMISS).Methods Through collecting,sorting and screening the TCM prescriptions for treating lymphoma applied by Professor FU Rulin from September 2012 to August 2015,standard data were input into the software of TCMISS (V2.0),and the data were statistically analyzes by using the software to explore clinical characteristics of Professor FU Rulin in treating lymphoma.Results A total of 55 standard prescriptions including 103 kinds of Chinese materia medica (CMM) were screened and analyzed.It could be preliminarily concluded that Professor FU Rulin was good at using CMM of invigorating Qi and nourishing Yin such as Radix Glehniae,Radix Adenophorae and Radix Paeoniae Alba in the treatment of lymphoma for supporting vital Qi.For resolving abdominal mass,he properly used CMM of nourishing Yin and resolving hard mass like Carapax Trionycis and Rhizoma Curcumae as auxiliaries,cooperating with CMM of clearing heat and removing toxicity such as Radix Ranunculi Ternati,Herba Hedyotis,Radix Glycyrrhizae and Spica Prunellae.Conclusion In the treatment of lymphoma,Professor FU Rulin mostly uses CMM of invigorating Qi and nourishing Yin,as well as resolving hard mass and removing toxicity,and selects CMM according to different clinical constitution states,mostly supplemented by CMM of regulating Qi and activating blood as well as resolving phlegm and removing dampness.Through the combination of various CMM,it eliminates pathogen and strengthens vital Qi,treating both manifestation and root cause of disease,to enhanced anti-cancer efficacy in many ways with remarkable clinical efficacy,so as to provide a new treatment strategy for better clinical use of CMM in the treatment of lymphoma.
作者
冷福玉
傅汝林
罗莉
唐东昕
王镜辉
柯龙珠
姜烨
李功卓
张兰
刘杰
LENG Fuyu;FU Rulin;LUO Li;TANG Dongxin;WANG Jinghui;KE Longzhu;JIANG Ye;LI Gongzhuo;ZHANG Lan;LIU Jie(Guizhou University of Traditional Chinese Medicine,Guiyang,Guizhou 550002,China;Guihang Guiyang Hospital,Guiyang,Guizhou 550006,China;The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine,Guiyang,Guizhou 550001,China;The First People's Hospital of Guiyang,Guiyang,Guizhou 550002,China)
出处
《湖南中医药大学学报》
CAS
2019年第9期1125-1128,共4页
Journal of Hunan University of Chinese Medicine
基金
国家自然科学基金地区科学基金(81673862,81660833,81760814)
贵州省科技厅(黔科合人才〔2016〕4032号)
贵州省教育厅(黔教研合GZS字〔2016〕08)
贵州省组织部(黔人领发〔2018〕3号)